FFuzkk Atlas of China
#155FUZKK selection 101–1000

Sinopharm Guorui

国药集团国瑞药业有限公司

#155

Baseline pharmaceutical scope

Manufacturing profile

Baseline pharmaceutical scope

Selection basis

The company was selected from a public production/supply universe as a legal entity with strong pharmaceutical-manufacturing indicators. Positions 101–1000 are FUZKK atlas priorities, not an official revenue ranking.

Score
210
Public source order
617
The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Confirm the actual product profile
  2. 2Inventory instruments and methods
  3. 3Supplier and incoming controls
  4. 4Calibration and process validation
  5. 5Data integrity and release readiness

Relevant FUZKK packages

China: national essential medicines QC packageLumex QC SuiteLabEx QC SuiteMedical Device QMS Suite

Product/API utilities

Assay & Impurities Result Reviewer

Lumex — instrumental QC

Genotoxic Impurity Screener M7Content Uniformity Acceptance ValueSystem Suitability Parameters Checker

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality Checker

Medical Devices — equipment and software lifecycle

Release Readiness CheckerSupplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerData Integrity Security CheckerRequirement Traceability Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand the scope.

Mapping boundary

The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Methodology